evidoria

← Back to browse

Good practice Imported

Auckland UniServices — University of Auckland's Research Commercialisation Company

New Zealand · Auckland · See the New Zealand profile · See the Auckland profile

Evidence: Observational / pre–post Top 54% 67/100 · Ask Evidence Copilot about this practice

New Zealand's oldest university commercialisation company: 45 active spin-outs worth a combined NZ$2.2bn, 540+ patent families licensed, and NZ$60m commercialisation revenue in 2022 — ranked #1 in Australasia by the independent SCOPR survey three years running.

45 companies
Active spin-outs (August 2025)
2.2 NZD billion
Combined enterprise value of spin-outs (August 2025)
540+ patent families
Patent families licensed (cumulative, 35 in 2024)
60 NZD million
Commercialisation revenue (2022)
3x ratio
Return on investment (15-year period to 2022)
400+ NZD million
Follow-on capital secured for portfolio companies (cumulative to 2022)
261 NZD million
Additional research revenue generated (15-year period to 2022)
41 NZD million
Inventors' Fund fair value (end of 2023)
Auckland UniServices — University of Auckland's Research Commercialisation Company

Details

Maturity
Established
Promoter
UniServices Limited (wholly owned by the University of Auckland)
Period
1988–present
Keywords
University technology transfer, research commercialisation, spin-outs

Context

UniServices is the University of Auckland's wholly owned research-commercialisation and technology-transfer company, established in 1988, managing contract research, IP licensing, custom education and spin-out creation, and ranked first in Australasia for active spin-out companies for three consecutive years by the SCOPR survey.

Activities

It manages the university's licensing portfolio and administers the University of Auckland Inventors' Fund, a pre-seed investment vehicle for early-stage inventions.

Results

As of August 2025, UniServices had 45 active spin-outs with a combined enterprise value of NZ$2.2 billion and had licensed 540+ patent families (35 in 2024 alone). Over the 15-year period to 2022, it generated NZ$60 million in commercialisation revenue (2022 figure), delivered an approximate 3x return on investment, secured NZ$400 million+ in follow-on capital for portfolio companies, and generated NZ$261 million in additional research revenue; the Inventors' Fund held a fair value of NZ$41 million at end-2023. In 2025 a US CDC-funded, UniServices-hosted vaccine-safety study lost its remaining funding after a DOGE review, and a teacher-support unit was absorbed into the commercial model after funding collapsed.

Implementation
Indicative cost
Medium (€50k–€500k) — Self-funded through licensing and commercialisation revenue plus a dedicated Inventors' Fund (NZ$41 million fair value, end-2023) for pre-seed investment.
Time to results
Long (> 3 years) — Operating since 1988 (35+ years); headline ROI and revenue figures are reported cumulatively over a 15-year window to 2022.
Staffing & skills
Dedicated commercialisation-company staff managing licensing, contract research and spin-out creation

Conditions for success

  • Full university ownership enabling long-term reinvestment
  • A dedicated pre-seed Inventors' Fund to bridge early-stage IP
  • Sustained multi-decade operation (since 1988)

Common failure modes

  • Dependence on external (including foreign-government) funding for hosted research programmes creates exposure, illustrated by the 2025 loss of a US CDC-funded, UniServices-hosted vaccine-safety study after a funding review, and the collapse of funding for a teacher-support unit

Where it fits

Governance type
university-owned commercialisation company
Scale
institutional (single university) with international revenue reach
Income level
high-income

Commonly funded by

National / regional programmes

Indicative funding routes for practices of this type — always check each programme's current calls and eligibility rules.

Do you run this practice? Claim it — verified implementers get a public contact pathway and can propose corrections.

Data sources

Where this practice's information was retrieved from, and when.

Attachments

Similar practices you may find useful